IBT
CLVS

International Biotechnology Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

International Biotechnology Trust’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-76,000
Closed -$4.01M – 64
2018
Q1 		$4.01M Hold
76,000
– – 1.57% 20
2017
Q4 		$5.17M Buy
76,000
+20,000
+36% +$1.4M 1.82% 20
2017
Q3 		$4.61M Buy
56,000
+21,000
+60% +$1.66M 1.8% 19
2017
Q2 		$3.28M Buy
35,000
+15,000
+75% +$918K 1.24% 28
2017
Q1 		$1.27M Sell
20,000
-55,000
-73% -$3.34M 0.49% 41
2016
Q4 		$3.33M Buy
+75,000
New +$2.64M 1.5% 16

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

International Biotechnology Trust's CLVS Position: Q2 2018 in Review

International Biotechnology Trust sold out of Clovis Oncology, Inc. (CLVS) in Q2 2018, closing a stake of 76,000 shares — an estimated $4.01M sold.

International Biotechnology Trust first reported a position in CLVS in Q4 2016 and held it in 6 quarters. The position peaked at $5.17M in Q4 2017. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

  • International Biotechnology Trust reported no remaining Clovis Oncology, Inc. position as of Q2 2018 after selling out during the quarter.
  • International Biotechnology Trust sold 76,000 Clovis Oncology, Inc. shares in Q2 2018, an estimated $4.01M.
  • International Biotechnology Trust first reported a position in Clovis Oncology, Inc. in Q4 2016 and held it in 6 quarters.
  • International Biotechnology Trust's Clovis Oncology, Inc. position peaked at $5.17M in Q4 2017.
  • 210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.